News
-
-
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Reports First Quarter 2026 Financials
Jaguar Health, Inc. reports significant revenue increase driven by license agreements for Mytesi® and Canalevia®-CA1, focuses on crofelemer development for rare intestinal indications. Upcoming presentations at ESPGHAN Meeting. Info on investor webcast and CEO's virtual presentation -
-
-
COMMUNIQUÉ DE PRESSE
Fox River Resources Corporation Obtains Interim Order for Plan of Arrangement and Provides Details of Special Meeting
Fox River Resources Corp. obtains interim court order for proposed arrangement with Avenir Minerals Ltd. Shareholders urged to vote on Arrangement Resolution by June 19 -
-
-
-